Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06897579 |
| Consolidated Lead Sponsor | Chia Tai Tianqing Pharmaceutical Group Co |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 40 participants (ACTUAL) |
| Registered Start Date | 2025-04-07 |
| WhyStopped Classification | Safety / Toxicity / Adverse Events |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing, China | Open Hospital Dossier -> |
| Peking University People's Hospital | Beijing, China | Open Hospital Dossier -> |
| Beijing Cancer Hospital | Beijing, China | Open Hospital Dossier -> |
| The Fourth Hospital of Hebei Medical University | Shijiazhuang, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.